Document is current
Any future updates will be listed below
-
Authors
Manara, Maria Cristina
Bruzzese, Francesca
Formentini, Laura
Landuzzi, Lorena
Pazzaglia, Laura
Laginestra, Maria Antonella
Carrabotta, Marianna
Roca, Maria Serena
Iannelli, Federica
Grumetti, Laura
Addi, Laura
Parra, Alessandro
Cristalli, Camilla
Pasello, Michela
Bavelloni, Alberto
Carreras, Francesca
Ruzzi, Francesca
Bianchi, Giuseppe
Gambarotti, Marco
Righi, Alberto
Budillon, Alfredo
Lollini, Pier-Luigi
Scotlandi, Katia
-
Funding
Funding for this research was provided by:
Rete ACC– “The ACC preclinical research platform for precision oncology.” (RCR-2022-23682287)
Rete ACC– “The ACC preclinical research platform for precision oncology.” (RCR-2022-23682287)
Fondazione AIRC Per la Ricerca sul Cancro ETS (IG2016-18451 and IG2019–22805)
- License Information
-
More Information
Article History
Received: 29 January 2025
Accepted: 9 June 2025
First Online: 8 July 2025
Declarations
:
: The study was approved by the ethics committee of Area Vasta Emilia Centro (CE-AVEC:505/2019/Sper/IOR). Written patient-informed consent forms were obtained for biobanking and establishment of PDX models; all methods were performed in accordance with institutional guidelines and Italian law. All animal procedures were performed in accordance with ARRIVE guidelines [] (European directive 2010/63/UE and Italian Law (DL 26/2014); experimental protocols were approved by the institutional animal care and use committee of the University of Bologna and by the Italian Ministry of Health (authorizations 782/2015-PR, 208/2017-PR, 755/2018-PR, 1051/2020-PR, and 179/2025-PR).
: Not applicable.
: The authors declare no competing interests.
